BIRC5 and breast carcinoma: Studies have shown conflicting results, with survivin expression being associated with poor prognosis, good prognosis, or no association with prognosis in patients with breast cancer patients.[18–21] In patients diagnosed with breast cancer, survivin expression is typically assessed by immunohistochemistry (IHC) or polymerase chain reaction (PCR) methods.